TreeWAS – Variant ID: rs8181477

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.898	0.102
H65.3 Chronic mucoid otitis media	0.000	0.907	0.093
H65 Nonsuppurative otitis media	0.000	0.910	0.090
H65.1 Other acute nonsuppurative otitis media	0.000	0.931	0.069
H65.4 Other chronic nonsuppurative otitis media	0.000	0.932	0.068
H65.2 Chronic serous otitis media	0.000	0.953	0.047
H65.0 Acute serous otitis media	0.000	0.954	0.046
T91.8 Sequelae of other specified injuries of neck and trunk	0.021	0.979	0.000
T91.1 Sequelae of fracture of spine	0.019	0.981	0.000
T91 Sequelae of injuries of neck and trunk	0.018	0.982	0.000
T91.9 Sequelae of unspecified injury of neck and trunk	0.014	0.985	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.013	0.986	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.013	0.986	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.013	0.986	0.000
Z98.8 Other specified postsurgical states	0.013	0.987	0.000
T91.3 Sequelae of injury of spinal cord	0.012	0.988	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.012	0.988	0.000
C91.1 Chronic lymphocytic leukaemia	0.010	0.990	0.000
T45.0 Antiallergic and antiemetic drugs	0.009	0.991	0.000
M31.6 Other giant cell arteritis	0.009	0.991	0.000
Q61.0 Congenital single renal cyst	0.009	0.991	0.000
K66.8 Other specified disorders of peritoneum	0.000	0.991	0.009
Q61 Cystic kidney disease	0.008	0.992	0.000
C91 Lymphoid leukaemia	0.008	0.992	0.000
C91.4 Hairy-cell leukaemia	0.008	0.992	0.000
D23.5 Skin of trunk	0.008	0.992	0.000
Q61.5 Medullary cystic kidney	0.007	0.993	0.000
Q61.9 Cystic kidney disease, unspecified	0.007	0.993	0.000
Q61.3 Polycystic kidney, unspecified	0.007	0.993	0.000
Q61.2 Polycystic kidney, adult type	0.007	0.993	0.000
M31 Other necrotising vasculopathies	0.007	0.993	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.994	0.000
C91.0 Acute lymphoblastic leukaemia	0.006	0.994	0.000
Q61.8 Other cystic kidney diseases	0.006	0.994	0.000
Q61.1 Polycystic kidney, infantile type	0.006	0.994	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.006	0.994	0.000
C91.7 Other lymphoid leukaemia	0.006	0.994	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.006	0.994	0.000
C91.5 Adult T-cell leukaemia	0.006	0.994	0.000
C91.3 Prolymphocytic leukaemia	0.006	0.994	0.000
C91.2 Subacute lymphocytic leukaemia	0.006	0.994	0.000
Q61.4 Renal dysplasia	0.006	0.994	0.000
D07.4 Penis	0.000	0.994	0.006
M31.4 Aortic arch syndrome [Takayasu]	0.006	0.994	0.000
T45.2 Vitamins, not elsewhere classified	0.006	0.994	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.006	0.994	0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.005	0.994	0.000
M31.9 Necrotising vasculopathy, unspecified	0.005	0.995	0.000
M31.1 Thrombotic microangiopathy	0.005	0.995	0.000
C91.9 Lymphoid leukaemia, unspecified	0.005	0.995	0.000
M31.8 Other specified necrotising vasculopathies	0.005	0.995	0.000
M31.0 Hypersensitivity angiitis	0.005	0.995	0.000
T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified	0.000	0.995	0.005
K66.1 Haemoperitoneum	0.000	0.995	0.005
M31.2 Lethal midline granuloma	0.005	0.995	0.000
S60.9 Superficial injury of wrist and hand, unspecified	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
M31.3 Wegener's granulomatosis	0.005	0.995	0.000
D07.1 Vulva	0.000	0.995	0.005
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.005	0.995	0.000
K74.3 Primary biliary cirrhosis	0.000	0.995	0.005
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.995	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.995	0.000
M31.7 Microscopic polyangiitis	0.005	0.995	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
K66 Other disorders of peritoneum	0.000	0.995	0.005
R10.0 Acute abdomen	0.005	0.995	0.000
T92 Sequelae of injuries of upper limb	0.005	0.995	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.004	0.995	0.000
J86.9 Pyothorax without fistula	0.000	0.996	0.004
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.004	0.996	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.000	0.996	0.004
T92.1 Sequelae of fracture of arm	0.004	0.996	0.000
C81 Hodgkin's disease	0.004	0.996	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.996	0.004
C81.9 Hodgkin's disease, unspecified	0.004	0.996	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.996	0.004
C82.2 Large cell, follicular	0.004	0.996	0.000
K25.3 Acute without haemorrhage or perforation	0.004	0.996	0.000
T98 Sequelae of other and unspecified effects of external causes	0.004	0.996	0.000
C82.3 Follicular lymphoma grade IIIa	0.004	0.996	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
C88 Malignant immunoproliferative diseases	0.004	0.996	0.000
Q60-Q64 Congenital malformations of the urinary system	0.004	0.996	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.004	0.996	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.996	0.004
T98.3 Sequelae of complications of surgical and medical care, not elsewhere classified	0.004	0.996	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.004	0.996	0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.004	0.996	0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
Q60.0 Renal agenesis, unilateral	0.004	0.996	0.000
D07.2 Vagina	0.000	0.996	0.004
T92.4 Sequelae of injury of nerve of upper limb	0.004	0.996	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
K74.0 Hepatic fibrosis	0.000	0.996	0.004
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.004	0.996	0.000
T95 Sequelae of burns, corrosions and frostbite	0.003	0.996	0.000
T90 Sequelae of injuries of head	0.004	0.996	0.000
C82.0 Small cleaved cell, follicular	0.003	0.996	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.003	0.996	0.000
C93 Monocytic leukaemia	0.003	0.996	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.003	0.997	0.000
I72.3 Aneurysm of iliac artery	0.003	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.003	0.997	0.000
I45.5 Other specified heart block	0.003	0.997	0.000
C82.6 Cutaneous follicle centre lymphoma	0.003	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.003	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.003	0.997	0.000
O82.1 Delivery by emergency Caesarean section	0.000	0.997	0.003
R73.9 Hyperglycaemia, unspecified	0.000	0.997	0.003
C82.4 Follicular lymphoma grade IIIb	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
T94 Sequelae of injuries involving multiple and unspecified body regions	0.003	0.997	0.000
C81.7 Other Hodgkin's disease	0.003	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
K90.9 Intestinal malabsorption, unspecified	0.003	0.997	0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.003	0.997	0.000
D07.6 Other and unspecified male genital organs	0.000	0.997	0.003
D07.3 Other and unspecified female genital organs	0.000	0.997	0.003
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.003	0.997	0.000
T92.0 Sequelae of open wound of upper limb	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.003	0.997	0.000
C81.3 Lymphocytic depletion	0.003	0.997	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
M79.09 Rheumatism, unspecified (Site unspecified)	0.003	0.997	0.000
C81.2 Mixed cellularity	0.003	0.997	0.000
K66.9 Disorder of peritoneum, unspecified	0.000	0.997	0.003
Q60.2 Renal agenesis, unspecified	0.003	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.003	0.997	0.000
H60.9 Otitis externa, unspecified	0.000	0.997	0.003
T98.2 Sequelae of certain early complications of trauma	0.003	0.997	0.000
T98.0 Sequelae of effects of foreign body entering through natural orifice	0.003	0.997	0.000
C81.1 Nodular sclerosis	0.003	0.997	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
M82.10 Osteoporosis in endocrine disorders (Multiple sites)	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
K74.1 Hepatic sclerosis	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
D07.0 Endometrium	0.000	0.997	0.003
T95.1 Sequelae of burn, corrosion and frostbite of trunk	0.003	0.997	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.003	0.997	0.000
C93.1 Chronic monocytic leukaemia	0.003	0.997	0.000
Q60.6 Potter's syndrome	0.003	0.997	0.000
Q60.5 Renal hypoplasia, unspecified	0.003	0.997	0.000
Q60.4 Renal hypoplasia, bilateral	0.003	0.997	0.000
Q60.3 Renal hypoplasia, unilateral	0.003	0.997	0.000
Q60.1 Renal agenesis, bilateral	0.003	0.997	0.000
T90.0 Sequelae of superficial injury of head	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
C83.6 Undifferentiated (diffuse)	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.003	0.997	0.000
C83.4 Immunoblastic (diffuse)	0.003	0.997	0.000
T90.3 Sequelae of injury of cranial nerves	0.003	0.997	0.000
H60 Otitis externa	0.000	0.997	0.003
I49.8 Other specified cardiac arrhythmias	0.000	0.997	0.003
T94.0 Sequelae of injuries involving multiple body regions	0.003	0.997	0.000
C69 Malignant neoplasm of eye and adnexa	0.003	0.997	0.000
C93.9 Monocytic leukaemia, unspecified	0.003	0.997	0.000
C93.7 Other monocytic leukaemia	0.003	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.003	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.003	0.997	0.000
C93.0 Acute monocytic leukaemia	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
T95.9 Sequelae of unspecified burn, corrosion and frostbite	0.003	0.997	0.000
T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved	0.003	0.997	0.000
T95.0 Sequelae of burn, corrosion and frostbite of head and neck	0.003	0.997	0.000
C95 Leukaemia of unspecified cell type	0.003	0.997	0.000
C83.1 Small cleaved cell (diffuse)	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.000	0.997	0.003
C69.9 Eye, unspecified	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
T95.8 Sequelae of other specified burn, corrosion and frostbite	0.003	0.997	0.000
Q64 Other congenital malformations of urinary system	0.003	0.997	0.000
H60.4 Cholesteatoma of external ear	0.000	0.997	0.003
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T90.1 Sequelae of open wound of head	0.003	0.997	0.000
C69.0 Conjunctiva	0.003	0.997	0.000
H60.0 Abscess of external ear	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
C94.7 Other specified leukaemias	0.002	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.997	0.000
C94.5 Acute myelofibrosis	0.002	0.997	0.000
C94.4 Acute panmyelosis	0.002	0.997	0.000
C94.3 Mast cell leukaemia	0.002	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.997	0.000
C94.1 Chronic erythraemia	0.002	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.997	0.000
C96.8 Histiocytic sarcoma	0.002	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.997	0.000
C96.3 True histiocytic lymphoma	0.002	0.997	0.000
C96.2 Malignant mast cell tumour	0.002	0.997	0.000
C96.1 Malignant histiocytosis	0.002	0.997	0.000
C96.0 Letterer-Siwe disease	0.002	0.997	0.000
I72.0 Aneurysm of carotid artery	0.003	0.997	0.000
J34.0 Abscess, furuncle and carbuncle of nose	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.003	0.997	0.000
T95.3 Sequelae of burn, corrosion and frostbite of lower limb	0.002	0.997	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.002	0.997	0.000
C83.3 Large cell (diffuse)	0.003	0.997	0.000
M82.1 Osteoporosis in endocrine disorders	0.002	0.997	0.000
T47.2 Stimulant laxatives	0.002	0.997	0.000
T90.8 Sequelae of other specified injuries of head	0.002	0.997	0.000
T95.2 Sequelae of burn, corrosion and frostbite of upper limb	0.002	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T47.4 Other laxatives	0.002	0.997	0.000
Q62.2 Congenital megaloureter	0.002	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T98.1 Sequelae of other and unspecified effects of external causes	0.002	0.998	0.000
Q62.8 Other congenital malformations of ureter	0.002	0.998	0.000
Q62.7 Congenital vesico-uretero-renal reflux	0.002	0.998	0.000
Q62.6 Malposition of ureter	0.002	0.998	0.000
Q62.4 Agenesis of ureter	0.002	0.998	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.002	0.998	0.000
Q62.1 Atresia and stenosis of ureter	0.002	0.998	0.000
Q62.0 Congenital hydronephrosis	0.002	0.998	0.000
D46 Myelodysplastic syndromes	0.002	0.998	0.000
C69.6 Orbit	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
C69.3 Choroid	0.002	0.998	0.000
C69.2 Retina	0.002	0.998	0.000
C83.0 Small cell (diffuse)	0.002	0.998	0.000
H60.8 Other otitis externa	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Q62.5 Duplication of ureter	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
H60.2 Malignant otitis externa	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
S91.3 Open wound of other parts of foot	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.002	0.998	0.000
H60.3 Other infective otitis externa	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
H65-H75 Diseases of middle ear and mastoid	0.000	0.998	0.002
H60.1 Cellulitis of external ear	0.000	0.998	0.002
J10.0 Influenza with pneumonia, influenza virus identified	0.000	0.998	0.002
T90.9 Sequelae of unspecified injury of head	0.002	0.998	0.000
C69.8 Overlapping lesion of eye and adnexa	0.002	0.998	0.000
C69.5 Lachrymal gland and duct	0.002	0.998	0.000
C69.4 Ciliary body	0.002	0.998	0.000
C69.1 Cornea	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
I72 Other aneurysm	0.002	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.002	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
D46.1 Refractory anaemia with sideroblasts	0.002	0.998	0.000
Q64.9 Congenital malformation of urinary system, unspecified	0.002	0.998	0.000
Q64.8 Other specified congenital malformations of urinary system	0.002	0.998	0.000
Q64.6 Congenital diverticulum of bladder	0.002	0.998	0.000
Q64.5 Congenital absence of bladder and urethra	0.002	0.998	0.000
Q64.4 Malformation of urachus	0.002	0.998	0.000
Q64.2 Congenital posterior urethral valves	0.002	0.998	0.000
Q64.1 Exstrophy of urinary bladder	0.002	0.998	0.000
Q64.0 Epispadias	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T92.9 Sequelae of unspecified injury of upper limb	0.002	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T90.4 Sequelae of injury of eye and orbit	0.002	0.998	0.000
I72.4 Aneurysm of artery of lower extremity	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
J86 Pyothorax	0.000	0.998	0.002
D46.5 Refractory anaemia with multi-lineage dysplasia	0.002	0.998	0.000
H60.5 Acute otitis externa, non-infective	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
C95.9 Leukaemia, unspecified	0.002	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.002	0.998	0.000
C70.0 Cerebral meninges	0.002	0.998	0.000
D07.5 Prostate	0.000	0.998	0.002
M82.19 Osteoporosis in endocrine disorders (Site unspecified)	0.002	0.998	0.000
M82.18 Osteoporosis in endocrine disorders (Other)	0.002	0.998	0.000
M82.17 Osteoporosis in endocrine disorders (Ankle and foot)	0.002	0.998	0.000
M82.16 Osteoporosis in endocrine disorders (Lower leg)	0.002	0.998	0.000
M82.15 Osteoporosis in endocrine disorders (Pelvic region and thigh)	0.002	0.998	0.000
M82.14 Osteoporosis in endocrine disorders (Hand)	0.002	0.998	0.000
M82.13 Osteoporosis in endocrine disorders (Forearm)	0.002	0.998	0.000
M82.12 Osteoporosis in endocrine disorders (Upper arm)	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
C70 Malignant neoplasm of meninges	0.002	0.998	0.000
C92 Myeloid leukaemia	0.002	0.998	0.000
C71.9 Brain, unspecified	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.998	0.000
D69.6 Thrombocytopenia, unspecified	0.002	0.998	0.000
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
D46.7 Other myelodysplastic syndromes	0.002	0.998	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.002	0.998	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.002	0.998	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.002	0.998	0.000
I72.2 Aneurysm of renal artery	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
J39.2 Other diseases of pharynx	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T94.1 Sequelae of injuries, not specified by body region	0.002	0.998	0.000
J10 Influenza due to identified influenza virus	0.000	0.998	0.002
T50.8 Diagnostic agents	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
H70 Mastoiditis and related conditions	0.000	0.998	0.002
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
N82.3 Fistula of vagina to large intestine	0.000	0.998	0.002
F00.9 Dementia in Alzheimer's disease, unspecified	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
H68 Eustachian salpingitis and obstruction	0.000	0.998	0.002
M85.64 Other cyst of bone (Hand)	0.002	0.998	0.000
D46.4 Refractory anaemia, unspecified	0.002	0.998	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.998	0.002
H67 Otitis media in diseases classified elsewhere	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.998	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.002	0.998	0.000
I72.5 Aneurysm and dissection of other precerebral arteries	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
X51.9 Unspecified place	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.002	0.998	0.000
C72.0 Spinal cord	0.002	0.998	0.000
H70.8 Other mastoiditis and related conditions	0.000	0.998	0.002
Q63.3 Hyperplastic and giant kidney	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
Z29 Need for other prophylactic measures	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Z90.6 Acquired absence of other parts of urinary tract	0.000	0.998	0.002
Q63.9 Congenital malformation of kidney, unspecified	0.002	0.998	0.000
Q63.8 Other specified congenital malformations of kidney	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
Z29.8 Other specified prophylactic measures	0.002	0.998	0.000
M79.08 Rheumatism, unspecified (Other)	0.002	0.998	0.000
D46.2 Refractory anaemia with excess of blasts	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
K65-K67 Diseases of peritoneum	0.000	0.998	0.002
C71.1 Frontal lobe	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
C70.9 Meninges, unspecified	0.002	0.998	0.000
C70.1 Spinal meninges	0.002	0.998	0.000
D39.1 Ovary	0.002	0.998	0.000
I72.1 Aneurysm of artery of upper extremity	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.001	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
X51.8 Other specified place	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
I05.0 Mitral stenosis	0.000	0.998	0.002
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
J10.8 Influenza with other manifestations, influenza virus identified	0.000	0.998	0.002
M79.0 Rheumatism, unspecified	0.002	0.998	0.000
Q63.2 Ectopic kidney	0.002	0.998	0.000
H70.2 Petrositis	0.000	0.998	0.002
H70.1 Chronic mastoiditis	0.000	0.998	0.002
X51.1 Residential institution	0.002	0.998	0.000
D16.4 Bones of skull and face	0.002	0.998	0.000
H68.1 Obstruction of Eustachian tube	0.000	0.998	0.001
H68.0 Eustachian salpingitis	0.000	0.998	0.001
H69 Other disorders of Eustachian tube	0.000	0.998	0.002
C72.9 Central nervous system, unspecified	0.001	0.998	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.001	0.998	0.000
C72.5 Other and unspecified cranial nerves	0.001	0.998	0.000
C72.4 Acoustic nerve	0.001	0.998	0.000
C72.3 Optic nerve	0.001	0.998	0.000
C72.2 Olfactory nerve	0.001	0.998	0.000
C72.1 Cauda equina	0.001	0.998	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.998	0.001
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.998	0.001
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.998	0.001
H70.9 Mastoiditis, unspecified	0.000	0.998	0.002
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.998	0.001
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
T36.0 Penicillins	0.001	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.001	0.998	0.000
X51 Travel and motion	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.998	0.000
T38.7 Androgens and anabolic congeners	0.001	0.998	0.000
T38.5 Other oestrogens and progestogens	0.001	0.998	0.000
T38.4 Oral contraceptives	0.001	0.998	0.000
T38.2 Antithyroid drugs	0.001	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations